drugset / Trial / NCT01389544

A Study on the Interaction Between Danoprevir/Ritonavir and Methadone

NCT01389544

Phase 1 Completed 18 enrolled Hoffmann-La Roche
NaSingle-groupOpen-label

Summary

This multicenter, open-label study will assess the effect of multiple doses of danoprevir/ritonavir on steady-state pharmacokinetics of methadone. Subjects on stable methadone maintenance therapy (20 - 120 mg daily as single oral morning dose) will receive danoprevir 100 mg orally twice daily and ritonavir 100 mg orally twice daily for 10 days.

Timeline

Start
2011-06
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 20 mg Oral
Subject Methadone Other / unclassified 120 mg Oral
Subject Ritonavir Other / unclassified 100 mg Oral
Subject danoprevir Small molecule 100 mg Oral

Indications

No indication recorded.